Urology News and Research

Latest Urology News and Research

ASI's GenASIs for detection of chromosomal aberrations in bladder cancer receives FDA approval

Applied Spectral Imaging (ASI) announced today that ASI's GenASIs Scan & Analysis, SpotScan used for the detection of chromosomal aberrations in bladder cancer has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.

30 Jan 2012

Submissions open for 6th Annual Excellence in Urology Health Reporting Awards

The American Urological Association (AUA) today announced that submissions are now being accepted for the 6th Annual Excellence in Urology Health Reporting Awards, designed to recognize outstanding news coverage of urologic disease topics. Presentation of the awards will take place during the AUA Annual Scientific Meeting in Atlanta, GA, in May.

30 Jan 2012

Constipation may be the culprit in bedwetting problems

Bedwetting isn't always due to problems with the bladder, according to new research by Wake Forest Baptist Medical Center. Constipation is often the culprit; and if it isn't diagnosed, children and their parents must endure an unnecessarily long, costly and difficult quest to cure nighttime wetting.

30 Jan 2012

Urological cancer experts to examine latest treatment, research findings at 27th Annual EAU Congress

International urological cancer experts will examine the latest treatment and research findings at the 27th Annual EAU Congress in Paris, France on 24-28 February 2012.

25 Jan 2012

Watson announces acquisition of Ascent Pharmahealth

Watson Pharmaceuticals, Inc. announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash.

24 Jan 2012

Dutasteride delays prostate cancer progression in men

For men diagnosed with low-risk, localized prostate cancer, being treated with the drug dutasteride delays disease progression and initiating active treatment, and also reduces anxiety, show the results of a three-year international clinical trial led by Dr. Neil Fleshner, Head of the Division of Urology, University Health Network.

24 Jan 2012

NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer

Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.

21 Jan 2012

TCRH forms new joint venture with Duke LifePoint

Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.

20 Jan 2012

New AACN Practice Alert on catheter-associated urinary tract infections

Urinary tract infections account for nearly 40 percent of hospital-acquired infections in acute care hospitals, triggering increased hospital costs and higher patient morbidity and mortality rates. Compounding the toll of these infections, Medicaid, Medicare and many other payers no longer reimburse costs related to treatment because of their presumed preventability.

19 Jan 2012

HOXB13 gene mutation linked to familial prostate cancer risk

The quest for genetic information in the fight against prostate cancer is nearly two decades long. While researchers and doctors have long accepted the hereditary nature of the disease, in that closer relatives are at a two-fold increased risk of developing prostate cancer, the genetic explanation remained a mystery. Last week geneticists shared news of a novel gene mutation linked to familial prostate cancer risk.

19 Jan 2012

Scientists crack genetic code for Schistosoma haematobium

Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.

19 Jan 2012

Alpha-hemolysin may play an unexpected role in UTIs

Researchers from the University of Utah have identified a process by which the most common types of urinary tract infection-causing bacteria are able to trigger bladder cell shedding and disable immune responses. According to this new study, published in the Jan. 19, 2012, issue of Cell Host & Microbe, α-hemolysin, a toxin secreted by many strains of Escherichia coli (E. coli), may play an important, unexpected role during both the establishment and persistence of urinary tract infections.

19 Jan 2012

Watson introduces new oral contraceptive, Vestura

Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Pharma, Inc. has launched Vestura(TM), a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Yaz(R) oral contraceptive product.

18 Jan 2012

Viewpoints: Health care is a civil right; A Medicare strategy based on Lenin

Martin Luther King Jr.'s legacy is one of progress toward a better life for every American, including equal opportunity in voting, housing, education, and employment. Reflecting on his legacy also means recognizing the steps we must take to address the inequalities that persist. Many of these involve health care. Poor and minority Americans suffer from more preventable diseases on average, lower-quality care, fewer treatment options, and less health insurance coverage.

18 Jan 2012

Innovative computer algorithm identifies clinically prognostic marker for cancer

Researchers at the Stanford University School of Medicine have used an innovative mathematical technique to find markers that effectively predict how deadly a cancer will be. The discovery, which in this case concerned bladder cancer, could lead to faster, less expensive and more accurate analysis of cancer risk and better treatment of the disease.

18 Jan 2012

Angioplasty improves quality of life in MS patients

Although using angioplasty to treat multiple sclerosis (MS) is highly controversial, sufferers often insist it helps - in some cases dramatically, such as allowing them to walk without a cane. Patients with less severe MS also reported additional quality of life improvements, such as being able to talk more clearly, after having treatment to open blocked blood vessels in the chest and neck, according to research being presented at the 24th annual International Symposium on Endovascular Therapy.

17 Jan 2012

Two emergency medicine physicians create weapon against lethal war injury

Two emergency medicine physicians with wartime experience have developed a weapon against one rapidly lethal war injury.

12 Jan 2012

Scientists identify rare genetic mutation linked to prostate cancer

After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.

12 Jan 2012

Bladder cancer is one of the top 10 most common forms of cancer in the US

Bladder cancer, most frequently caused by smoking and exposure to carcinogens in the workplace, is one of the top 10 most common forms of cancer in men and women in the U.S. More than 70 percent of bladder cancers are diagnosed in stage T1 or less and have not invaded the muscle layer.

11 Jan 2012

Telormedix raises 7.5 million CHF

Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised 7.5 Million CHF from existing investors Aravis Venture and Proquest Investments.

10 Jan 2012